PLSE - Pulse Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development9,6465,5062,18144.571
Selling General and Administrative15,5033,4151,62173.714
Non Recurring----
Total Operating Expenses25,8149,5864,468308.571
Operating Income or Loss-25,814-9,586-4,468-308.571
Income from Continuing Operations
Total Other Income/Expenses Net24768--205.714
Earnings Before Interest and Taxes-25,814-9,586-4,468-308.571
Interest Expense----
Income Before Tax-25,567-9,518-4,468-514.286
Income Tax Expense---1,657-39.429
Minority Interest----
Net Income From Continuing Ops-25,567-9,518-2,811-474.857
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-25,567-9,518-2,811-474.857
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-25,567-9,518-2,811-474.857